EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Anti-oestrogens and bone






Annales d'Endocrinologie 56(6): 603-608

Anti-oestrogens and bone

Anti-oestrogens are a class of non-steroid compounds with, depending on the tissue, oestrogen-antagonist or oestrogen-agonist actions resulting from different mechanisms, especially by binding to oestrogen receptors. These compounds are commonly called anti-oestrogens because of their extensive use in treating breast cancer. Tamoxifen, the first of these complex compounds, has a partial agonist effect on the endometrium and also affects bone and lipid metabolism. Currently, our knowledge of anti-oestrogen action on bone is based on experimental work and a few clinical trials with tamoxifen. The animal studies show that tamoxifen has a preventive effect against bone hyper-remodelling resulting form ovariectomy in the rat. Most of the clinical studies, including the most recent, show that tamoxifen has no deleterious effect, and possibly even a moderate protective effect against bone loss, in menopaused women. This effect on bone tissue, together with lowered plasma cholesterol levels, has led to the development of other compounds with a bone and lipid agonist effect and secondary effects limited to endometrial hyperplasia. Third generation compounds include droloxifen keoxifen (or raloxifen) currently under investigation. This research should lead to wider indications for anti-oestrogens in the prevention of the effects of post-menopause oestrogen deficiency, particularly in patients with contraindications for oestrogen therapy.


Accession: 009770174



Related references

Hartmann, R.W.; Sinchai, T.; Kranzfelder, G., 1985: Anti-proliferative effects of 1,2-diphenylethane oestrogens and anti-oestrogens on human breast cancer cells. The anti-tumour activities of 1,2-diphenylethane oestrogens (hexoestrol and orthohexoestrol) and anti-oestrogens (metahexoestrol, tetramethylHES, and metatetramethylHES) were studied on the human MCF-7 and MDA-MB-231 breast cancer cell lines. On t...

Emmens, C.W.; Finn, C.A., 1962: Local and parenteral action of oestrogens and anti-oestrogens on early pregnancy in the rat and mouse. In the mouse, a variety of oestrogens and anti-oestrogens given by a single injection on the 4th day of pregnancy inhibit implantation. Local administration to a segment of one horn of the uterus caused inhibition with lower dosage levels than wer...

Humphrey, K.W.; Martin, L., 1968: The effects of oestrogens and anti-oestrogens on ovum transport in the laboratory mouse. Australian Journal of Biological Sciences 21(6): 1239-1248

Waters, A.P.; Wakeling, A.E.; Knowler, J.T., 1983: A rationalization of the effects of anti-oestrogens and oestrogens on uterine RNA synthesis in the immature rat. A series of oestrogens and anti-oestrogens have been compared with respect to their effects on RNA synthesis in the uterus of immature rats. The normal transcriptional response to oestrogen is a biphasic stimulation of transcription. The first pha...

Martin, L.; Cox, R.I.; Emmens, C.W., 1963: Further studies on the effects of oestrogens and anti-oestrogens on early pregnancy in mice. A number of synthetic anti-estrogens interrupted early pregnancy in mice. It is not clear, however, whether they do so by reason of their anti-estrogenic or pro-estrogenic activity since, in the series tested, both properties are highly correlated...

Baudendistel, L.J.; Ruh, M.F.; Nadel, E.M.; Ruh, T.S., 1978: Cytoplasmic oestrogen receptor replenishment: oestrogens versus anti-oestrogens. The effect of the in vivo administration of various triphenylethylene antioestrogens and physiological (0.05 microgram) versus pharmacological (0.5--5 microgram) doses of oestradiol-17 beta (Oe2) on the uterotrophic process in general and the nucl...

Green, S., 1990: Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens. The oestrogen receptor is a member of a supergene family that includes receptors for steroid and thyroid hormones, vitamin D3, and retinoic acid. A number of additional members of the family have been cloned where the putative ligand remains to be...

Emmens, C.W., 1962: Action of oestrogens and anti-oestrogens on early pregnancy in the rabbit. Mated female rabbits were injected subcutaneously on Days 5 to 7 or 7 to 9 of pregnancy with various substances in nut oil, and examined on Days 9 to 11. Approximately 50% failure of normal implantation was caused by 30 [mu]g of oestradiol, 25 mg...

Martin, L.; Emmens, C.W.; Cox, R.I., 1960: The effects of oestrogens and anti-oestrogens on early pregnancy in mice. The capacity of various oestrogens and anti-oestrogens to inhibit early pregnancy in the mouse was compared. Both classes of compound are effective, but there remains some doubt as to the mode of action of anti-oestrogens, since they are also oest...

Karg, H.; Braunmuhl, T.V.; Vogt, K., 1969: Oestrogens and anti-oestrogens in feeds. 2. Use of a biological screeningtest for samples of lucerne, grass, maize and chinchilla feed. For part 1 see Title 3598, Vol. 38. 2. White mice were spayed at the age of 21 to 23 days and then used in groups of 8 each for test and control diets. For the anti-oestrogen test they were given from the second day after operation 0.1 micro g oes...